Tinea Versicolor
Recent clinical, regulatory, research and industry developments relating to this disease.
<i>Malassezia</i>-Associated Skin Diseases, the Use of Diagnostics and Treatment.
What's happening now
An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.
- 1 clinical trial with recent milestones.
Clinical MilestonesViewHide
Clinical trials
The current development programme across all trial phases.
Research activity
Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.
Major themes4
- Dermatitis, Seborrheic1
- Folliculitis1
- Malassezia1
- Tinea Versicolor1
Leading journals1
- Frontiers in cellular and infection microbiology1
Leading researchers3
- Gaitanis G1
- Hay RJ1
- Saunte DML1
Affiliations (unnormalised)5
- DELC Clinic1
- Department of Clinical Medicine1
- School of Health Sciences1
- St. Johns Institute of Dermatology1
- Zealand University Hospital1
Reference
Authoritative identity, definition & identifiers.
A common chronic, noninflammatory and usually symptomless disorder, characterized by the occurrence of multiple macular patches of all sizes and shapes, and varying in pigmentation from fawn-colored to brown. It is seen most frequently in hot, humid, tropical regions and is mostly caused by MALASSEZIA FURFUR (formerly Pityrosporum orbiculare).
- Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
- Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
- Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
- Related entities are derived from literature co-mention (studied together) — associative, not causal.